TScan Therapeutics (TCRX) Prepaid Assets (2020 - 2026)

TScan Therapeutics (TCRX) has reported Prepaid Assets for 7 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 49.63% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 49.63% YoY), while the FY2025 annual figure was $4.8 million, up 83.84% from the prior year.
• Prepaid Assets fell to $4.7 million in Q1 2026 per TCRX's latest filing, from $4.8 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $5.3 million in Q1 2023 and bottomed at $1.4 million in Q2 2023.
• Historically, Prepaid Assets has averaged $3.3 million across 5 years, with a median of $3.1 million in 2025.
• Annual changes were most pronounced in 2024 — Prepaid Assets slumped 63.43% — and 2025, when it jumped 83.84%.
• TScan Therapeutics' Prepaid Assets stood at $4.1 million in 2022, then plunged by 46.51% to $2.2 million in 2023, then rose by 19.11% to $2.6 million in 2024, then surged by 83.84% to $4.8 million in 2025, then dropped by 1.94% to $4.7 million in 2026.
• Business Quant data shows TCRX's Prepaid Assets at $4.7 million in Q1 2026, $4.8 million in Q4 2025, and $3.7 million in Q3 2025.